DICUMAROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dicumarol, and when can generic versions of Dicumarol launch?
Dicumarol is a drug marketed by Lilly and Abbvie and is included in two NDAs.
The generic ingredient in DICUMAROL is dicumarol. There is one drug master file entry for this compound. Additional details are available on the dicumarol profile page.
Summary for DICUMAROL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 1 |
Patent Applications: | 5,153 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DICUMAROL at DailyMed |
Recent Clinical Trials for DICUMAROL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Bologna | Phase 4 |
Medical Subject Heading (MeSH) Categories for DICUMAROL
US Patents and Regulatory Information for DICUMAROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | DICUMAROL | dicumarol | CAPSULE;ORAL | 005509-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Abbvie | DICUMAROL | dicumarol | TABLET;ORAL | 005545-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | DICUMAROL | dicumarol | CAPSULE;ORAL | 005509-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |